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ABSTRACT
Despite the loss of sequence-specific DNA binding,
mutant p53 (mutp53) proteins can induce or repress
transcriptionofmutp53-specifictargetgenes.Todate,
the molecular basis for transcriptional modulation by
mutp53 is not understood, but increasing evidence
points to the possibility that specific interactions of
mutp53 with DNA play an important role. So far, the
lack of a common denominator for mutp53 DNA bind-
ing,i.e.theexistenceofcommonsequenceelements,
hashamperedfurthercharacterizationofmutp53DNA
binding. Emanating from our previous discovery that
DNA structure is an important determinant of wild-
type p53 (wtp53) DNA binding, we analyzed the bind-
ing of various mutp53 proteins to oligonucleotides
mimicking non-B DNA structures. Using various
DNA-binding assays we show that mutp53 proteins
bind selectively and with high affinity to non-B DNA.
In contrast to sequence-specific and DNA structure-
dependent binding of wtp53, mutp53 DNA binding to
non-BDNAissolelydependentonthestereo-specific
configuration of the DNA, and not on DNA sequence.
We propose that DNA structure-selective binding of
mutp53 proteins is the basis for the well-documented
interaction of mutp53 with MAR elements and for
transcriptional activities mediates by mutp53.
INTRODUCTION
Sequence-speciﬁc transactivation underlies the growth suppr-
essing and apoptotic functions of wild-type p53 (wtp53) (1,2).
Substitution of a single amino acid residue within the central
DNA-binding domain (DBD) (the characteristic feature of
the p53 mutational spectrum) affects sequence-speciﬁc DNA
binding (SSDB). Loss of p53-SSDB and impaired ability to
elicit the same transcriptional response as wtp53 are the hall-
marks of mutant p53 (mutp53) proteins, which are generally
considered to be transcriptionally inactive. However, the iden-
tiﬁcation of genes that can be induced speciﬁcally by mutp53,
but not by wtp53 (3), indicates that mutp53 proteins may not
necessarily be disqualiﬁed as transcriptional activators. The
functional spectrum of the so far known mutp53-responsive
genes strongly suggests that some mutp53 proteins target a set
of genes that is different from those controlled by wtp53.
Furthermore, transactivation by mutp53 not only appears to
be target gene-speciﬁc, but also mutp53-speciﬁc to date, as
promoters regulated by a speciﬁc mutp53 protein may not be
responsive to other p53 mutants (4). In addition, the cellular
context seems to be important for mutp53 target gene speci-
ﬁcity. So far, neither the mechanism of mutp53 transactivation
nor how the speciﬁcity of mutp53 transactivation is achieved
is known. Although modulation of transcription by mutp53
proteins, similar to wtp53, can occur via protein–protein inter-
actions (4–9), the ability of mutp53 proteins to regulate tran-
scription by directly binding to DNA is a possibility (10–12).
The assumption is consistent with the requirement of the cent-
ral DNA binding and of the regulatory C-terminal domains
for transcriptional activity of mutp53 (13,14) in addition to
N-terminal transactivation domains (15).
The identiﬁcation of parameters important for mutp53 inter-
action with DNA is of paramount importance in light of the
possibility that the ability to activate transcription by direct
binding to mutp53-regulated promoters may underlie the
cancer-promoting effects of mutp53 proteins (16–18). DNA
bindingofmutp53proteinscanbesupportedeitherbypartially
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DNA-binding activities that appear speciﬁc yet distinct
from SSDB (10,12,21). However, the lack of a common
denominator, such as the presence of a speciﬁc sequence-
motif in the DNA that is recognized by mutp53 proteins,
poses a major difﬁculty in delineating the parameters that
determine speciﬁcity of mutp53 DNA binding. Several cog-
nate motifs identiﬁed as putative binding sites for different
mutp53 proteins exhibit no sequence similarity, suggesting
that sequence-speciﬁc DNA recognition may not be the
mode determining DNA binding of mutp53.
An important consideration in delineating the parameters of
mutp53 DNA binding is that this activity most probably
derives from DNA-binding activities inherent to wtp53.
Wtp53 binds DNA by various modes that can be formally
divided into SSDB and non-SSDB. Non-SSDB of wtp53
includes high-afﬁnity binding to double-stranded DNA (22)
andsingle-strandedDNAends(23),secondaryDNAstructures
such as Holliday junctions (24), t-loop junctions in telomeric
DNA (25), cruciforms (26), and to aberrant sites in DNA such
as mismatched bases and DNA bulges (27,28). It has been
proposedthatthevariousmodesofDNAbindingareassociated
with different activities of wtp53, with SSDB-mediating
p53 transcriptional control, mismatch/bulged DNA binding
being associated with p53 activities in DNA repair
or recombination, and binding to single-stranded DNA ends
implicated as an initial step in DNA strand transfer (29).
However, it appears that the various types of DNA binding
are not only speciﬁc for certain activities of wtp53, but also
contribute to its major activity—SSDB and transcriptional
activation [reviewed in (30)]. Wtp53-SSDB can occur in dif-
ferent modes depending on the conformation of p53-binding
sites,eithersequence-speciﬁctolinear(B-)DNA,orsequence-
and structure-speciﬁc to non-B DNA (31–36). In contrast to
SSDB to linear DNA, which most probably is mediated solely
by the p53 core DBD (37,38), sequence-speciﬁc and DNA
structure-dependent SSDB to non-linear DNA and non-
SSDB modes of DNA interaction involve both the DBD and
the CTD (C-terminal domain) (33,34,39,40). The p53 CTD,
which has been previously implicated exclusively in ‘unspe-
ciﬁc’ DNA binding, appears to be an important constituent of
SSDBasitstabilizessequence-speciﬁcbindingofthep53DBD
to wtp53-cognate motifs when they adopt a non-B DNA con-
formation (33). Supporting the notion, the potentiating effects
of the CTD were revealed when wtp53-SSDB and transactiva-
tion was examined under conditions more closely resembling
p53 interaction with chromatin (40). The complex picture
emerging from these ﬁndings reveals that not only the various
DNA-binding activities of the p53 core domain, but also the
DNA-binding activity of the p53 CTD has strong impact on
wtp53-SSDB.
The changing picture of wtp53-SSDB also puts the issue of
mutp53-speciﬁc DNA binding in a new perspective. Our
laboratory has previously analyzed DNA binding of mutp53
proteins in some detail (41–44). The complex interactions of
mutp53withDNA were showntorequireboththe mutated p53
DBD and the intact p53 CTD (43). As mutp53 proteins have
not only lost the wtp53-SSDB activity, but are also impaired
for high-afﬁnity binding to unspeciﬁc linear DNA, an activity
which in wtp53 is mediated by the DBD and the CTD
[reviewed in (45)]; unspeciﬁc binding to linear DNA is
unlikely to underlie the interactions of mutp53 with DNA.
The conclusion is compatible with our previous ﬁndings
that the DNA sequences bound by mutp53 in vitro and
in vivo predominantly contain repetitive sequences (44) with
a high propensity to undergo structural transitions.
As DNA conformation plays an important role in the
DNA binding of wtp53 and mutp53, and as DNA structure-
dependent binding of wtp53 and mutp53 requires the CTD,
which is intact in most of the frequently encountered mutp53
proteins, we investigated whether DNA binding of mutp53
proteins may be determined by the recognition of DNA struc-
ture. We analyzed DNA binding of different mutp53 proteins
to conformationally distinct forms of DNA by using electro-
mobility shift assay (EMSA), confocal ﬂuorescence lifetime
analysis (cFLA) and a novel p53 protein array-based DNA-
binding assay. Our results demonstrate that ‘hot spot’ mutp53
proteins, while having lost sequence-speciﬁc DNA recogni-
tion, have retained the potential to bind non-linear DNA in a
DNA structure-dependent manner. DNA structure-dependent
binding of mutp53 does not require the presence of speciﬁc
sequence motifs. Nevertheless, DNA binding of mutp53 is
not unspeciﬁc, as it is highly selective for secondary DNA
structures that fulﬁll speciﬁc structural criteria. Therefore, we
termed the mode of mutp53 DNA binding as ‘DNA structure-
selective binding’ (DSSB) and propose that it has important
implications for the activities elicited by mutp53 in cancer
cells.
MATERIALS AND METHODS
Protein purification and EMSA
Recombinant p53 proteins expressed in insect cells were
isolated as described previously (33) and puriﬁed by ion-
exchange chromatography (FPLC; Amersham Bioscience).
DNA-binding experiments were performed using 50 ng or
the indicated amounts of recombinant p53 proteins in a reac-
tion mixture containing 5 ng of poly(dI:dC) (Amersham
Bioscience) and 2 mg of BSA in 50 mM Tris–HCl (pH 7.5),
0.1 mM EDTA, 1 mM dithiothreitol (DTT) and 50 mM NaCl.
After a 20 min preincubation at room temperature, 2 ng of
the radioactively labeled DNA probe (20–30000 c.p.m.) was
added, and the incubation was continued for another 25 min.
Samples were loaded onto a 4% native polyacrylamide gel and
separated by electrophoresis in 10 mM Tris–HCl (pH 7.8),
0.2 mM EDTA, 1.25 mM NaOAc and 8 mM acetic acid at
200 V for 2.5 h at room temperature. After electrophoresis,
the gels were dried and subjected to autoradiography.
Preparation of p53-binding substrates in linear or
non-linear DNA conformation
DNA probes used in EMSA were prepared from synthetic
oligonucleotides listed in Table 1. p53-binding sites presented
in linear or non-linear DNA conformation were prepared
as described previously (33). Brieﬂy, short radiolabeled
oligonucleotide T3-1 lacking the p53-speciﬁc sequence was
annealed with long unlabeled oligonucleotides p21stem–loop
or SCRstem–loop to obtain speciﬁc or unspeciﬁc stem–loop
structures, respectively. Resulting stem–loop structures
were separated from non-annealed single-stranded oligo-
nucleotides by electrophoresis in 8% native polyacrylamide
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conventional annealing of complementary oligonucleotides
p21lin/s and p21lin/as of which one was radioactively labeled.
Double-stranded linear DNA was eluted and puriﬁed after
separationin 8% native polyacrylamide gels. A four-way junc-
tion DNA was prepared as described in the original paper
by Duckett et al. (46) by hybridizing four oligonucleotides
(b-, h-, r- and x-strand) of which one was radioactively labeled
at the 50 end. The resulting four-way junction structure was
puriﬁed using Sephadex G-25 columns.
DNA binding using Mut p53 express array
Mutant p53 protein arrays containing 49 recombinant p53
proteins (200 pg of each protein spotted in duplicate) were
purchased from SenseProteomics (UK). DNA-binding experi-
ments were performed according to the manufacturer’s recom-
mendations. Brieﬂy, arrays were washed three times with 2 ml
of DNA-binding buffer (25 mM HEPES, pH 7.4, 50 mM KCl,
1 mg/ml BSA, 20% glycerol, 0.1% Triton X-100 and 1 mM
DTT) for 5 min. After washing, membranes were incubated
with puriﬁed radiolabeled DNA in 2 ml of the assay buffer for
30 min at room temperature. Unbound DNA was removed by
three washing steps (5 min each) with 2 ml of DNA-binding
buffer. In competition assays, the binding step was followed
by 30 min incubation at room temperature with unlabeled
DNAspec that contains p53-cognate motif in linear conforma-
tion at a molar ratio of 1:1 and 1:5 of labeled DNA probe/
unlabeled competitor DNA. In experiments addressing the
inﬂuence of p53 antibodies on DNA binding, the arrays
were ﬁrst incubated with 4 mg of puriﬁed PAb421 antibody
for 30 min at room temperature, followed by the addition of
DNA. In all the experiments p53-bound DNA was detected
by autoradiography.
DNA binding by cFLA
All measurements were performed with a FCS+plus research
reader (Evotec Technologies, Hamburg). The working
principal of cFLA and the mathematics underlying the quan-
tiﬁcation of read-outs has been described elsewhere (47,48).
In brief, the sample is optically excited by a fast pulsed laser
system (Lynx-VAN-532; Time-Bandwidth, Switzerland)
running at 80 MHz repetition rate and an average power of
 5 mW. The pulse width is <350 ps and the pulse-to-pulse
distance is <20 ns. The laser beam passes through an objective
lens and is focused onto the sample. The ﬂuorescence light is
collected by the same objective lens and separated from the
excitation light by suitable optical ﬁlters. A photon counting
device, i.e. an avalanche photodiode (APD) (SPCM-AQ-131;
EG&G Optoelectronics, Vaudreuil, Quebec, Canada), records
the emitted ﬂuorescence light. The electronic data processing
is performed by a high time resolution acquisition electronics
based on Time-to-Digital-Converters (TDCs). The TDCs
thereby measure and digitize the temporal distances between
the arrival times of detected ﬂuorescence photons and the last
excitational laser pulse.
In vitro ubiquitination assay
Insect cells expressing recombinant GST-Mdm2 protein (49)
were suspended in PBS and brieﬂy sonicated. The supernatant
was centrifuged at 15000 g for 30 min and applied to the
glutathione–Sepharose 4B (Pharmacia) column. GST-Mdm2
was eluted with 10 mM reduced glutathione and 50 mM Tris–
HCl (pH 8.0) and analyzed using western blot with anti-
MDM2 antibody Ab2A10. An aliquot of 50 ng of recombinant
p53 protein was incubated with increasing amounts of DNA in
50mMTris–HCl(pH7.5),0.1mMEDTA,1mMDTT,50mM
NaCl, 2 mg BSA and 5 ng poly(dI
 dC) for 20 min. After
preincubation, 150 ng GST-Mdm2, 250 ng E1 (Calbiochem),
500 ng UbcH5 (Calbiochem) and 15 mg ubiquitin (Sigma)
were added. Ubiquitination was performed in a reaction mix-
ture (40 ml) containing 50 mM Tris–HCl (pH 7.4), 5 mM
MgCl2, 2 mM ATP and 2 mM DTT for 90 min at 25 C.
Samples were resolved by 10% SDS–PAGE and p53 was
detected by immunoblotting using anti-p53 antibody DO1.
Table 1. Oligonucleotides used in the study
Oligonucleotides Sequence DNA substrate Figure
T3-1 50-ccgcggtaccattacctaaggcgtc-30 Linear DNAunspec 1 and 4
T3-2 50-gacgccttaggtaatggtaccgcgg-30
b-strand 50-tccgtcctagcaagccgctgctaccggaag-30 Four-way junction
a
h-strand 50-cttccggtagcagcgagagcggtggttgaa-30 1 and 2
r-strand 50-ttcaaccaccgctcttctcaactgcagtct-30
x-strand 50-agactgcagttgagagcttgctaggacgga-30
T3-1 50-ccgcggtaccat–tacctaaggcgtc-30 Stem–loop DNAunspec 2–4
SCRstem–loop 50-gacgccttaggta–cctgccctcgctcgctcacc–gtgcgctggctggatggtaccgcgg-30
T3-1 50-ccgcggtaccat–tacctaaggcgtc-30 Stem–loop DNAunspec23
SCRstem–loop25 0-gacgccttaggta–ccagcctccgcacgctcacc–gagcgctggcagg–atggtaccgcgg-30
T3-1 50-ccgcggtaccat–tacctaaggcgtc-30 Stem–loop DNAspec
b 3–5
p21stem–loop 50-gacgccttaggta–cctgccGAACATGTCCCAACATGTTGggcctg–atggtaccgcgg-30
T3-1 50-ccgcggtaccat–tacctaaggcgtc-30 Stem–loop DNACON
b 3C
CON-loop 50-gacgccttaggta–cctggcctgcctGGACTTGCCTggcctgcctgg–atggtaccgcgg-30
T3-1 50-ccgcggtaccat–tacctaaggcgtc-30 Stem–loop DNACON-2
b 3C
CON-2 50-gacgccttaggta–cctggcctgccaGGACTTGCCTggcaggccagg–atggtaccgcgg-30
p21lin/s 50-gctctgccGAACATGTCCCAACATGTTGccgctctg-30 Linear DNAspec 5
p21lin/as 50-cagagcggCAACATGTTGGGACATGTTCggcagagc-30
aSequences and nomenclature of oligonucleotides used for the preparation of four-way junction DNA were adopted from the original study by Duckett et al. (46).
bSequencecorrespondingtothep53bindingsitefromthep21promoterortothep53consensusareshowninuppercaseletters.Underlinedsequencescorrespondto
complementary regions. Regions forming the stem of stem–loop structures are shown by ‘–’.
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Mutp53 proteins bind preferentially to non-linear DNA
To test whether DNA topology may be a relevant parameter
for mutp53 DNA binding, we used EMSA to examine the
binding of mutp53 proteins to DNA substrates, comprising
four-way junction DNA or stem–loop structures, which are
the twotypesofsecondary DNAstructurestowhich wtp53can
bind with high afﬁnity (24,33). Figure 1A shows that mutp53
proteins, 273H, 248P and 245S, while being unable to bind
linear double-stranded DNA (shown for mutp53 proteins
273H and 248P, lanes 1–10), did bind to a DNA structure
resembling a four-way junction in Holliday structures
(Figure 1A and B, lanes 11–20 and lanes 6–9, respectively).
Wtp53 also bound four-way junction DNA albeit rather
weakly (Figure 1B, lanes 1–5). The binding of wtp53 and
different mutp53 proteins to four-way junction DNA exhibited
marked quantitative differences. The apparent binding afﬁnity
was higher for 248P and 245S mutants compared with 273H
mutant [compare lanes 16–20 in Figure 1A and 6–9 in Figure
1B with lanes 11–15 in Figure 1A, respectively], which bound
weakly, with an efﬁciency comparable with that of wtp53
(compare lanes 11–15 in Figure 1A with lanes 1–5 in Figure
1B). Furthermore, mutp53 proteins also exhibited different
patterns of binding. Mutp53 273H and mutp53 248P formed
one major complex with four-way junction DNA, which
increased correspondingly with protein input (Figure 1A,
lanes 11–20). A different pattern was observed with mutp53
245S: two major complexes a and b were formed at low con-
centrations of the 245S protein (Figure 1B, lane 6). Further
increasing the protein input led to the appearance of slower
migrating complexes c and d (lanes 7 and 8, complexes indic-
ated by arrowheads), which paralleled the concomitant
decrease of complexes a and b that eventually disappeared
at higher 245S concentrations (lanes 7–9 in Figure 1B). Com-
plexes a, b, c and d could be further supershifted by the p53-
speciﬁc antibody DO-1 conﬁrming that they were formed by
mutp53 245S p53 (datanot shown). The binding pattern exhib-
ited by mutp53 245S at low concentrations qualitatively
resembled that of wtp53, which also formed two complexes
with four-way junction DNA at high concentrations, albeit
very weakly (Figure 1B, lane 5), in line with the much
lower capacity of wtp53 to bind four-way junction DNA com-
pared with mutp53 245S. Although the precise composition of
complexes a,b,cand disunclear, the patternsuggestsa highly
co-operative mode of binding with the slowly migrating com-
plexes representing higher order oligomeric forms of G245S.
Interestingly, mutp53 proteins 273H and 248P formed only
one complex and did not form higher order oligomeric forms
with four-way junction DNA even at high concentrations (Fig-
ure 1A, lower panel) indicating that different p53 mutants bind
four-way junction DNA by different modes.
A
273H  
p53 (ng): - 10 25 50 100
1     2      3     4     5 6 7 8 9 10
248P
- 10 25 50 100
Free DNA
273H  
p53 (ng): - 10 25 50 100
248P
5 10 25 50 100
11 12 13 14 15 16 17 18 19 20
Free DNA
B
Free DNA
p53 (ng):
9 12345 678
245S wt p53     
- 50 75 100 150 50 75 100 150
a
b
c
d
Figure 1. Analysis of mutp53 DNA binding by EMSA. (A) Hot-spot p53
mutp53 proteins 273H, 245S and 248P were incubated with linear DNAunspec
lackingap53-specificcognatemotif(upperpanel).Bindingofmutp53proteins
273H and 248P to a four-way junction structure (lower panel). Four-way
junction structure was prepared as described in Materials and Methods by
annealing fourintercomplementary oligonucleotides b, h, r and x (the resulting
structure is shown schematically), of which one was radioactively labeled.
Arrowheads indicate p53 complexes formed with different types of DNA
probes, as shown by the corresponding symbols in this and in other figures.
(B) Binding of wtp53 and 245P proteins to a four-way junction structure.
1090 Nucleic Acids Research, 2005, Vol. 33, No. 3We next examined mutp53 binding to stem–loop DNA,
which represent another type of secondary DNA structures
bound by wtp53 (33). Conﬁrming our previous ﬁndings,
wtp53boundweaklytostem–loopstructuresformedbyunspe-
ciﬁc (i.e. lacking the p53 consensus) stem–loop DNAunspec
(Figure 2A). In contrast, mutp53 proteins 248P and 245S
bound strongly to stem–loop DNAunspec (Figure 2A, compare
lanes 7–10 and 11–14, respectively). Of note, the complex
formed by mutp53 with stem–loop migrated with a mobility
similar to that of the complex formed by wtp53 (Figure 2A,
compare the complex in lane 2 with the complex in lanes 9, 10,
13 and 14). Since wtp53 binds stem–loop as a tetramer (33),
we conclude from this observation that mutp53 also binds
stem–loop structure as tetramer. Interestingly, only very little
higher order protein/DNA complexes were formed between
mutp53 245S and stem–loop DNA, underscoring the notion
that this protein binds stem–loop and four-way junction DNA
in different modes. In contrast to 245S and 248P proteins,
mutant 273H did not form stable complexes with stem–loop
DNAunspec even at high concentrations (Figure 2A, lanes 3–6).
SSDB of wtp53 to non-linear DNA requires the C-terminal
domain and is strongly inhibited by the C-terminal antibody
A
free DNA
p53 (ng):
273H 248P 245S
10 25 50 100 10 25 50 100 10 25 50 100 0  100
wtp53
11  10 9 8 7 6 5 4 3 2 1   12    13    14
B
248P 245S
1     2     3     4    5     6    7
p53:   - +    +    +   +                                   +     +   +     +      +     +
Ab421:   +
+
- -
+
--+   - - ++
DO-1: --- + -- +     - +    --+ -
8     9   10    11   12   13
245S 248P
Free DNA Free DNA
-- -
Figure 2. (A) Binding of mutp53 proteins 273H, 245S and 248P to a stem–loop structure formed by unspecific DNA (stem–loop DNAunspec). (B) Effects
of p53-specific antibodies PAb421 and DO-1 on mutp53 interaction with non-linear DNA structures. An aliquot of 50 ng of p53 proteins were incubated
with DNA in the presence or absence of 200 ng of the purified antibody.
Nucleic Acids Research, 2005, Vol. 33, No. 3 1091PAb421 (31–34). Examination of the effects of p53 speciﬁc
antibodies revealed that PAb421, but not the N-terminal
antibody DO-1, strongly inhibited the binding to stem–loop
DNA (Figure 2B, lanes 1–7) as well as to four-way junction
DNA (lanes 8–13). The inhibitory effect of PAb421 indicates
that the C-terminus is involved in non-linear DNA binding
of mutp53. Signiﬁcantly, incubation of all mutp53 proteins
with stem–loop DNAunspec led to the appearance of a smeary
tail (lanes 6, 10 and 14 in Figure 2A and lanes 2 and 5 in
Figure 2B), which may be due to the dissociation of unstable
protein/DNA complex during electrophoresis or due to the
DNA structure disturbing effects caused by p53 binding. Inter-
estingly, we repeatedly observed that the addition of DO-1 led
to the appearance of several supershifted bands (indicated by
parentheses in Figure 2B). One explanation of such effects
of DO-1 may be that not all p53 molecules may be equally
accessible for antibody binding in the mutp53 tetramer bound
to non-linear DNA. Alternatively, it is possible that DO-1 may
have promoted the formation of high-order p53 oligomers on
non-linear DNA.
The local structure of non-linear DNA, not the presence
of specific sequence motifs determines the selectivity of
mutp53 DNA binding
High-afﬁnity SSDB of wtp53 is dependent on two crucial
parameters, the presence of the p53-speciﬁc sequence and
the appropriate conformation of the DNA (33,34). In contrast,
mutp53 proteins bind to non-B DNA also in the absence
of the consensus sequence (Figure 2A). Indeed, as shown in
Figure 3A, mutp53 proteins 245S and 248P bound stem–loop
DNAspec containing p53-speciﬁc sequence (lanes 1–7) and
stem–loop DNAunspec (lanes 8 and 9) with comparable efﬁ-
ciencies, indicating that mutp53 DNA binding is not determ-
ined by a speciﬁc sequence. Whereas the presence or absence
of a p53 consensus sequence had no signiﬁcant impact on
mutp53 DNA binding, the base composition of structural ele-
ments in the stem–loop DNA, such as mismatches or bulges,
strongly inﬂuenced the efﬁciency of binding (Figure 3B,
shown for mutp53 248P). We reckon that the most probably
explanation for the strong inﬂuence of individual bases
p53:   - + + +    +     +     +              - +    +    +     +      +    +
Ab421:   --+ - +     - +              --+ - +     - +
1     2     3     4     5    6     7             8     9   10   11   12   13   14
273H 248P 245S 273H 248P 245S
Stem-loop DNAspec Stem-loop DNAunspec
c 
t   a
c    c
gc
cg
a        a
cg
gc
cg
c   c
t   t 
cg
cg
gc
a      a
cg
cg 5‘
c 
t   a
c    c
gc
cg
t   t
cg
gc
cg
t   c
c   t 
cg
cg
gc
t   t
cg
cg 5‘
1       2      3      4       5 6   7      8      9     10
248P (ng): 0 5 10 25 50 0 5 10 25 50
Stem-loop DNASCR Stem-loop DNASCR-2
AB
1092 Nucleic Acids Research, 2005, Vol. 33, No. 3on mutp53 binding to non-linear DNA is a different 3D con-
ﬁguration of the secondary DNA structure, which greatly
depends on the base composition. Therefore, we conclude
that non-linearity of DNA as such is not sufﬁcient to qualify
for mutp53 DNA binding and that stereo-speciﬁc criteria have
to be fulﬁlled to promote mutp53 binding to secondary DNA
structures. Intriguingly, stem–loop structures that either lack
or contain mismatched bases were bound with comparable
efﬁciency by mutp53 proteins 248P (Figure 3C, lanes 3 and
11) and 245S (data not shown). The ability of mutp53 to bind
stem–loop structures lacking mismatched bases is in striking
contrast to the requirement of mismatched bases for efﬁcient
stem–loop binding by wtp53 (Figure 3C, compare lanes 2
and 10), as reported previously (33). These results indicate
that the potential of mutp53 to bind non-linear DNA not only
is retained in mutp53 proteins, but also can be altered by
mutations in the central DBD. As a consequence, a different
spectrum of DNA structures can be bound by mutp53 proteins
compared with that of wtp53.
Quantitative analysis of mutp53 binding to
non-linear DNA
Our EMSA experiments suggested that mutp53 proteins 245S
and 248P bind non-linear DNA with high afﬁnity, whereas
mutp53 273H appeared to be a weak binder. We evaluated
the binding afﬁnities of mutp53 proteins 273H, 245S and 248P
with different types of DNA, using cFLA. Fluorescence life-
time represents an intrinsic molecular property of the ﬂuoro-
phore and is able to detect minute changes in the ﬂuorophore’s
direct environment, like binding processes. In brief, cFLA is
explained as follows: using an objective lens, the pulsed laser
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Figure 3. Impact of the p53-specific sequence-motif and of mismatched bases on DNA binding of mutp53. (A) Stem–loop structures either containing (stem–loop
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Nucleic Acids Research, 2005, Vol. 33, No. 3 1093light emitting at a wavelength of 532 nm is focused onto a
sample, which illuminates a volume of  1 ﬂ (with a diameter
of  1 mm). The ﬂuorescence light is collected by the same
objective lens and separated from the excitation light by suit-
able optical ﬁlters. A photon counting device, i.e. an APD,
records the emitted ﬂuorescence light. The electronic data
processing is performed by a high time resolution acquisition
electronics based on TDC. The TDCs thereby measure and
digitize the temporal distances between the arrival times of
detected ﬂuorescence photons and the last excitational laser
pulse. From the recorded data, the lifetime from the bound and
unbound state of the used samples can be determined and
quantiﬁed. The binding curves for mutp53 248P and 273H
are shown in Figure 4 and visualize the differences in binding
afﬁnities between mutp53 248P and mutp53 273H in binding
to stem–loop DNAunspec, and in binding to linear DNAunspec.
The read-outs of the cFLA experiments are summarized in
Table 2 and show that mutp53 proteins 248P and 245S
bind stem–loop DNAunspec with high afﬁnity (11.2 – 5.0 and
40.2 – 6.0 nM, respectively), which is comparable with that
determined for SSDB of wtp53 to stem–loop DNAspec
(35.9 – 5.1 nM). In contrast, binding of mutp53 273H
was signiﬁcantly weaker (248 – 70.3 nM). Furthermore,
conﬁrming the results of our EMSA experiments, all mutp53
proteins exhibited a low afﬁnity toward linear DNA (Table 2),
which is in contrast to wtp53 that binds linear DNA with
high afﬁnity (22). Thus, the results of the cFLA studies
fully support the conclusions drawn from our EMSA experi-
ments, and show that mutp53 proteins 245S and 248P bind
to non-linear DNA with high afﬁnity in a DNA structure-
selective mode.
248P [nM]
Stem-loop DNAunspec Linear DNAunspec
248P [nM]
273H [nM] 273H [nM]
Linear DNAunspec Stem-loop DNAunspec
Figure 4. Graphic representation showing typical results of mut p53 DNA-binding analyses using cFLA (shown for 273H and 248P). The results of all the cFLA
experiments are summarized in Table 2.
Table 2. DNA-binding affinities determined by cFLA
Protein KD (nM) DNA Number of experiments
273H 155 – 15 Linear DNAunspec 3
248P 159 – 32 — 3
245S 464 – 104 — 2
273H 248 – 70 Stem–loop DNAunspec 3
248P 11.2 – 5.0 — 4
245S 40 – 6.0 — 2
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many mutp53 proteins
We next investigated whether non-linear DNA binding may be
a peculiar feature of the G245Sand R248Pmutp53 proteins, or
whether it may be a more general feature of mutp53 proteins.
Since only a limited number of recombinant mutp53 pro-
teins were at our disposal, we took advantage of a mutp53
protein array that contains 49 different mutp53 proteins and
allows simultaneous on-array monitoring of DNA binding
(graphic representation of the mutp53 protein array and
on-array immunodetection of p53 proteins with PAb240 and
PAb421 are shown in Supplementary Figures 1A and B,
respectively). We examined DNA binding of mutp53 proteins
to radioactively labeled DNA in stem–loop or in linear con-
formation. Since linear as well as non-linear DNA binding
of wtp53 is dependent on the presence of a p53 consensus
sequence (33,34), we used DNAspec containing a p53 con-
sensus sequence, allowing us to compare non-linear DNA
binding of mutp53 with that of wtp53, which is also present
on the array. The arrays were incubated with radioactively
labeled DNAspec in stem–loop or linear DNA conformation,
and bound DNA was detected after repeated cycles of washing
as described in Materials and Methods. While very few non-
hot spot mutp53 proteins with mutations outside the DBD
bound both stem–loop DNAspec and linear DNAspec, none
of the hot-spot mutp53 proteins present on the array appre-
ciably bound linear DNA (Figure 5A). In contrast, most
mutp53 proteins, including all hot-spot mutants, did bind
strongly to stem–loop DNA (data summarized in Table 3),
indicating that non-linear DNA is a preferred binding substrate
for the majority of mutp53 proteins. In this assay, also mutp53
273H bound to stem–loop DNA, which is in apparent contrast
to our EMSA and cFLA data. Although we cannot rule out the
possibility that the difference is due to the set-up of the assay,
we consider it likely that it is due to the different (PAb240-
positive) conformation of the bacterially expressed mutp53
273H protein as compared with the PAb240-non-reactive
form, which is the predominant conformation of 273H
expressed in insect cells. As PAb240-positivity reﬂects the
accessibility of an epitope in the p53 DBD, the ability of
273H in a PAb240-reactive form to bind non-linear DNA
further supports the notion that the p53 DBD is involved in
non-linear DNA binding. The efﬁciency of non-linear DNA
binding by mutp53 proteins correlated directly with their
reactivity to PAb240, suggesting that an ‘open’ DBD in
mutp53 proteins may promote binding to non-linear DNA.
SupportingourcFLAresults,competitionexperimentsdemon-
strated that non-linear DNA binding of mutp53 proteins is a
high afﬁnity interaction, as an excess of unlabeled linear
double-stranded DNA, while effectively displacing radioact-
ive linear DNA from the complex with mutp53 (arrays shown
in the upper panel of Figure 5B), had only a marginal effect on
stem–loop DNA binding (Figure 5B, middle panel). The spe-
ciﬁcity of binding was further conﬁrmed by the ﬁnding that
PAb421 signiﬁcantly inhibited binding of stem–loop DNAspec,
as was the case in our EMSA experiments (Supplementary
Figure 1C). Altogether, the results demonstrate that DNA
structure-selective binding is a property inherent to many
mutp53 proteins, which bind preferentially and with high
afﬁnity to non-linear DNA.
DISCUSSION
We demonstrate in this study that mutp53 proteins bind
speciﬁcally and selectively to DNA in a non-linear DNA con-
formation, and that binding is determined by recognition of
DNA topology. Therefore, we termed this mode of DNA
binding as DSSB. In contrast to the high-afﬁnity binding of
wtp53 to non-linear DNA, which requires the presence of a
p53-speciﬁc sequence motif (33,34), high-afﬁnity DSSB of
mutp53 is determined solely by a favorable stereo-speciﬁc
DNA conformation (this study). In addition to having lost
theabilitytobindDNA sequence speciﬁcally,mutp53proteins
are also impaired for high-afﬁnity interaction with linear
DNA (22) (Figure 1A). High-afﬁnity DNA binding of mutp53-
DSSB, thus is restricted to non-linear DNA. In contrast to
the previous view that the mutp53 proteins are either DNA
binding inactive or bind to DNA in an unspeciﬁc manner, the
striking selectivity toward non-linear DNA, and the require-
ment for a stereo-speciﬁc DNA conformation provide mutp53
proteins with features of DNA structure-speciﬁc DNA-binding
proteins.
Despite the distinct modes of DNA recognition, some
mechanistic aspects are similar in mutp53-DSSB and in
wtp53-SSDB. Both, mutp53-DSSB and wtp53-SSDB require
the p53 DBD and the CTD for high-afﬁnity binding. The CTD
is important for mediating stable complex formation of p53
with non-linear DNA in mutp53-DSSB (this study) and in
wtp53-SSDB (33,34,40). However, the possibility that the
C-terminus might impact non-linear DNA binding of mutp53
by supporting the appropriate quarternary structure of mutp53
proteins should also be considered. In fact, our on-array
binding analyses showing that none of the oligomerization-
deﬁcient mutp53 proteins was capable of binding to DNA is in
accordance with the idea. While the CTD is a major regulator
of mutp53-DSSB, the core DBD appears to play an important
role in the speciﬁcity of mutp53-DSSB. Underscoring the
importance of non-linear DNA binding as a major mode of
interaction of mutp53 with DNA, we found that mutants
with an ‘open’, i.e. PAb40-positive DBD also bind better to
non-linear DNA. The requirement of an open DBD for non-
linear DNA binding would explain why DNA contact mutants
such as 273H bound less efﬁciently than conformational
p53 mutants to the DNA substrates analyzed here. Another
possibility is that the differing afﬁnity of mutp53 proteins may
beduetothefactthatthe‘designed’DNAstructuresusedhere,
while better suited for binding of some (245S and 248P)
mutp53 proteins, may be poorly compatible with binding of
other mutants such as 273H. Again, such mutation-dependent
selectivity toward different DNA structures would not be
surprising considering that individual mutations affect the
conformation of the p53 core domain differently (50). Further
supporting the idea, our results show that the spectrum of
secondary DNA structures bound by mutp53 proteins is
different and probably much broader from that of wtp53.
The identiﬁcation of genomic sequences bound by individual
mutp53 proteins in chromatin might be helpful for delineating
the optimal structural binding sites for mutp53 proteins such
as 273H, which while being potent DNA-binding proteins
in vivo may behave as weak binders with rationally designed
structures in vitro. We are currently analyzing a library of
genomic sequences obtained by a ChIP-based approach (44)
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Figure 5. Analyses of DNA binding by using mutp53 protein arrays. (A) Autoradiograph of radioactively labeled DNAspec bound to p53 proteins. Mutp53 arrays
wereincubatedwithDNAspecpresenteitherinlinearorinstem–loopconformation,washedandexposedtoX-rayfilmforautoradiographicdetection,amplifiedwith
the aid of an intensifying screen at  70 C. Positions of wtp53 and mutp53 proteins 273H and 245S that were analyzed also by other assays are indicated by circles.
Dottedlinesindicateexclusivebindingofstem–loopDNAspecbythosemutantsthatfailedtobindlinearDNAspec.Theresultsofbindingexperimentsaresummarized
in Table 3,in whichdifferent mutp53proteinshave beengroupedaccording to their abilityto bindnon-linearDNA.The apparentbindingaffinity wasevaluatedby
densitometry whereby the intensity of the signal produced by p53-306X mutant lacking the oligomerization and the C-terminal domains was considered as
background(designatedas‘ ’ in Table 3).To scorethe bindingto linear DNA,intensitiesthatwere equalto or consistedat least 50%of thevalue corresponding to
wtp53bindingweredesignatedas‘++’.Forstem–loopDNAbinding,intensitieshigherthanatleast10%ofthevalueobtainedforthesameproteinwithlinearDNA
weredesignatedas‘+++’.(B)DNAcompetitionassay.ArrayswerefirstincubatedwithlinearDNAspec(upperpanel)orwithstem–loopDNAspec(lowerpanel),and
bound DNAwas detectedusing autoradiography.The muchweakersignal compared with imagesshownin (A)is dueto more gentleconditionsof autoradiography
(shorter exposure time at room temperature under moist conditions) that were used for the sake of preserving protein–DNA complex. After the documentation
of DNA binding, the p53–DNA complex were challenged by two sequential rounds of competition with a 1:1 and 1:5 molar excess of unlabeled linear DNAspec.
The lower panel shows a control array that was treated under identical conditions except that the competitor DNA was omitted.
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Preliminary analyses reveal that sequences bound by mutp53
273H in chromatin exhibit repetitiveness, which is a charac-
teristic feature of structurally ﬂexible DNA, and to an above-
average percentage contain variations of the DNA unwinding
motif ‘AATATATTT’ (M. Brazdova, G. Tolstonog and
W. Deppert, manuscript in preparation), which had been pre-
viously shown to be recognized by mutp53 273H in vitro (42).
Repetitiveness and ﬂexibility thus seem to be common denom-
inators of DNA bound by mutp53 proteins. Such parameters
are characteristic for MAR/SAR elements, which were the
initially identiﬁed DNA sequences bound by various
mutp53 proteins (42,43). Secondary DNA structures formed
by MAR/SAR sequences are extremely ﬂexible due to their
high content of repetitive sequences (often AT-rich) and dif-
ﬁcult to reconstitute in vitro with short DNA. In chromatin,
however, MAR/SAR elements are very stable and can form
facultative secondary structures due to their large size (kilo-
base range). Taken together, all data available support the idea
that DNA-structure-selective binding of mutp53 proteins as
described here is the base for MAR/SAR binding of mutp53
proteins described originally by our laboratory (42,43) and
conﬁrmed by other groups (51).
The ﬁnding that mutp53 can bind with high afﬁnity to non-
canonic DNA structures formed by p53-speciﬁc sequences
seems discrepant to the fact that mutp53 cannot activate
transcription from wtp53 responsive elements in vivo. One
explanation may be that mutp53 proteins may in fact bind
to wtp53-response elements when they adopt a non-linear
conformation, but the outcome of such binding could be dif-
ferent from wtp53-SSDB. Transcriptional activation requires
the assembly of a stereo-speciﬁc nucleoprotein complex (pre-
initiation complex) between the activator and the components
of the basal transcriptional machinery at the speciﬁc pro-
moters. Wtp53 and mutp53 proteins interact differently
with general transcription co-activators, such as TAFII31 (52),
TAFII40 and TAFII60 (53). Therefore, the complex of mutp53
bound to non-linear DNA may not be favorable for the assem-
bly of an active pre-initiation complex. Alternatively, the
stability of secondary structures formed within p53-
response elements may be the limiting factor. Considering
that self-complementarity within the p53-cognate motifs
is not continuous but, as a rule, is interrupted by individual
non-matching bases, stem–loop structures formed by p53-
response elements are unlikely to be stable. Therefore, it is
possible that speciﬁc conditions may be required to
support the formation of a non-linear conformation within
wtp53-response elements. The possibility that such conditions
may not be fulﬁlled in cells with mutp53 is intriguing. In such
a scenario, one would have to assume that some activity indu-
cing alterations in the local DNA topology within or nearby
p53-bindingsites shouldbepresentincells with wtp53,butnot
in cells with mutp53. In fact, such a hypothetic activity may be
inherent to the wtp53 protein itself. In this regard, it is worth
considering that binding to linear DNA, which is severely
impaired in mutp53 proteins [(22); this study] appears to be
an important intermediate step and may be even a pre-requisite
for wtp53-SSDB. According to the recently proposed model of
‘p53 linear diffusion’, unspeciﬁc binding to linear DNA may
be of crucial importance for wtp53-SSDB, as it may allow
wtp53 to ‘slide’ along the duplex until it comes across a spe-
ciﬁc site where it then forms a stable sequence-speciﬁc com-
plex (36). In contrast to wtp53, mutp53 proteins are impaired
in their ability to bind linear DNA. This may explain why
mutp53 will not bind to non-canonic DNA structures formed
by wtp53-response elements in vivo: they cannot ﬁnd such
structures because the potential to slide along linear DNA
duplex is diminished in mutp53 proteins. An important
implicationwouldbethatmutp53-bindingsitesmaybelimited
to DNA structures that are constitutively present in a con-
formation that favors binding of mutp53, e.g. MAR/SAR
DNA elements.
Constitutive binding to non-B DNA structures might also
contribute to the strongly increased metabolic stability of
mutp53 proteins in vivo. We have observed that in vitro
ubiquitination of mutp53 proteins by Mdm2 is effectively
inhibited in the presence of stem–loop DNA (Figure 6,
lanes 3–6) whereas the impact of linear DNA is minimal
(lanes 7–10). The DNA-dependent protection from ubiquitina-
tion reﬂected the potential of different mutp53 proteins to bind
non-linear DNA. Indeed, stem–loop DNA had virtually no
effect on the ubiquitination of mutp53 protein R273H,
which binds weakly (lanes 3–6 in the lower panel), whereas
the strongly binding mutp53 protein R248P was efﬁciently
protected under the same conditions (lanes 3–6 in the upper
panel). Whether such mechanism operates in cells remains
unknown. However, considering that the basal expression
of Mdm2 is sustained by wtp53-independent mechanisms
either transcriptionally, via the p53-independent P1 promoter
(54–57), or post-transcriptionally (58), the constitutive bind-
ing to secondary DNA structures may be relevant for protect-
ing mutp53 from degradation by basal levels of Mdm2.
The binding of mutp53 proteins to non-B DNA structures
might also be the basis for the proposed augmentation
of recombination by mutp53 (59,60). Unusual secondary DNA
structures are intrinsically recombinogenic as they can be
recognized as high-afﬁnity substrates for DNA topology-
dependent recombinogenic factors, such as topoisomerases,
ligases and DNA structure-dependent binding proteins. The
constitutiveinteractionofmutp53proteinswithtopoisomerases
I and II correlates with higher rates of gene ampliﬁcation
(60) and raises the intriguing possibility that mutp53 proteins
bound to secondary structures in DNA may attract recombino-
genic factors and thereby promote genomic instability.
Table 3. DNA-binding patterns of wt and 49 mutp53 proteins
Protein Linear
DNAspec
Stem–loop
DNAspec
wtp53 ++ +++
273H; 245S;
273C; 245C; 245D;
248W; 248Q;
219S; 220C; 233D; 235D; 241F;
252P; 256I; 257Q; 265P; 266A;
272L; 278L; 280K; 133T; 152L;
141Y; 151S;154V;
175H;
180K; 193R;82L
  +++
181H; 82L; 23G; 23A; 72P; 181C;
227T; 306P; 392A
++ +++
D196; D209; D213; D306; 235S;
251M; 258K; 344P; 337C
  
Nucleic Acids Research, 2005, Vol. 33, No. 3 1097In conclusion, our ﬁndings reveal for the ﬁrst time that
mutant forms of p53 are DNA-binding active proteins, which
speciﬁcallybindDNAinaDNAstructure-selectivemodethatis
different from sequence-speciﬁc DNA interaction of wtp53.
The striking selectivity of mutp53 proteins toward non-linear
DNAisaccompaniedbythelossoflinearDNAbinding,which
is an important component of wtp53-SSDB. We propose that
the loss of sequence-speciﬁc and unspeciﬁc binding to linear
DNAcombinedwithenhancedbindingtonon-linearDNAisan
important parameter underlying the oncogenic activities,
increased stability and nuclear accumulation and the gain-of-
function phenomenon associated with mutp53 proteins.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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